Benjamin J. Lesch
Impact in
-
- Innovation and Socioeconomic Development
- Aging top 10%
Papers in
-
- CRISPR and Genetic Engineering 3
- Pluripotent Stem Cells Research 1
- Oncology 2
- CAR-T cell therapy research 1
- PARP inhibition in cancer therapy 1
- Co-authors
- Matthew H. Porteus (4 shared papers)M. Kyle Cromer (4 shared papers)Kenneth I. Weinberg (1 shared paper)Sruthi Mantri (1 shared paper)Mark A. Behlke (1 shared paper)Beruh Dejene (1 shared paper)Joab Camarena (1 shared paper)Daniel P. Dever (1 shared paper)
- Partner nations
- United StatesIndia
In The Last Decade
Benjamin J. Lesch
4 papers receiving 729 citations
Benjamin J. Lesch's Hit Papers
Peers
Comparison fields: 5 of 58
- Business and International Management 69
- Aging 37
- Molecular Biology 679
- Genetics 258
- Oncology 119
Countries citing papers authored by Benjamin J. Lesch
This map shows the geographic impact of Benjamin J. Lesch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin J. Lesch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin J. Lesch more than expected).
Fields of papers citing papers by Benjamin J. Lesch
This network shows the impact of papers produced by Benjamin J. Lesch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin J. Lesch. The network helps show where Benjamin J. Lesch may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin J. Lesch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Identification of preexisting adaptive immunity to Cas9 proteins in humans Hit paper breakdown → | 2019 | 665 |
| 2 | 2020 | 72 | |
| 3 | 2025 | 4 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 |
About Benjamin J. Lesch
Benjamin J. Lesch is a scholar working on Molecular Biology, Oncology, Hematology, Infectious Diseases and Virology, having authored 5 papers that have together received 742 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (3 papers), CAR-T cell therapy research (1 paper), HIV Research and Treatment (1 paper), Cytomegalovirus and herpesvirus research (1 paper), PARP inhibition in cancer therapy (1 paper), Erythropoietin and Anemia Treatment (1 paper), HIV/AIDS drug development and treatment (1 paper) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Business and International Management (69 citations), Aging (37 citations), Molecular Biology (679 citations), Genetics (258 citations) and Oncology (119 citations). Benjamin J. Lesch has collaborated with scholars based in United States and India. Frequent co-authors include Matthew H. Porteus, M. Kyle Cromer, Kenneth I. Weinberg, Sruthi Mantri, Mark A. Behlke, Beruh Dejene, Joab Camarena, Daniel P. Dever, Michael A. Collingwood and Viktor T. Lemgart. Their work appears in journals such as Nature Communications, Nature Medicine and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.